Skip to main content
Premium Trial:

Request an Annual Quote

Coffee, Anyone?


A new study published in the Journal of the National Cancer Institute adds to the growing body of evidence that says coffee is good for you, reports the Boston Globe's Deborah Kotz. The study shows that drinking "copious amounts" of coffee may reduce a man's risk of dying from prostate cancer, Kotz says. Study participants who drank one to three cups a day had a 30 percent lower risk of prostate cancer, and those who drank six cups a day had a 60 percent lower risk, the study's authors say. And whether the coffee is caffeinated or not doesn't matter, they add — the benefits were realized even if the men drank decaf. And women who drink coffee may see some protection against breast cancer, Kotz says. A team of Swedish researchers recently reported that women who drink five or more cups of coffee per day had about a 55 percent lower risk of developing a less common type of breast cancer that doesn't depend on estrogen, compared with women who only drink one cup per day.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more